Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.

Oleinika K, Rosser EC, Matei DE, Nistala K, Bosma A, Drozdov I, Mauri C.

Nat Commun. 2018 Feb 15;9(1):684. doi: 10.1038/s41467-018-02911-y.

2.

Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.

Binns EL, Moraitis E, Maillard S, Tansley S, McHugh N, Jacques TS, Wedderburn LR, Pilkington C, Yasin SA, Nistala K; UK Juvenile Dermatomyositis Research Group (UK and Ireland).

Pediatr Rheumatol Online J. 2017 Oct 31;15(1):77. doi: 10.1186/s12969-017-0205-x.

3.

Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.

Deakin CT, Yasin SA, Simou S, Arnold KA, Tansley SL, Betteridge ZE, McHugh NJ, Varsani H, Holton JL, Jacques TS, Pilkington CA, Nistala K, Wedderburn LR; UK Juvenile Dermatomyositis Research Group.

Arthritis Rheumatol. 2016 Nov;68(11):2806-2816. doi: 10.1002/art.39753. Epub 2016 Oct 9.

4.

Consensus-based recommendations for the management of juvenile dermatomyositis.

Enders FB, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, Lahdenne P, Magnusson B, Nistala K, Ozen S, Pilkington C, Ravelli A, Russo R, Uziel Y, van Brussel M, van der Net J, Vastert S, Wedderburn LR, Wulffraat N, McCann LJ, van Royen-Kerkhof A.

Ann Rheum Dis. 2017 Feb;76(2):329-340. doi: 10.1136/annrheumdis-2016-209247. Epub 2016 Aug 11. Review.

5.

The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.

Rider LG, Nistala K.

J Intern Med. 2016 Jul;280(1):24-38. doi: 10.1111/joim.12444. Epub 2016 Mar 30. Review.

6.

Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.

Campanilho-Marques R, Almeida B, Deakin C, Arnold K, Gallot N, de Iorio M, Nistala K, Pilkington CA, Wedderburn LR; Juvenile Dermatomyositis Research Group.

Arthritis Care Res (Hoboken). 2016 Oct;68(10):1514-21. doi: 10.1002/acr.22867. Epub 2016 Sep 16.

7.

Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is Underestimated.

Almeida B, Campanilho-Marques R, Arnold K, Pilkington CA, Wedderburn LR, Nistala K; Juvenile Dermatomyositis Research Group.

Arthritis Rheumatol. 2015 Sep;67(9):2495-502. doi: 10.1002/art.39200.

8.

The quest for personalized B-cell depletion therapy in rheumatic disease.

Nistala K, Mauri C.

Arthritis Res Ther. 2014;16(3):116.

9.

Interleukin-35 takes the 'B' line.

Mauri C, Nistala K.

Nat Med. 2014 Jun;20(6):580-1. doi: 10.1038/nm.3594. No abstract available.

PMID:
24901562
10.

T cell expression of granulocyte-macrophage colony-stimulating factor in juvenile arthritis is contingent upon Th17 plasticity.

Piper C, Pesenacker AM, Bending D, Thirugnanabalan B, Varsani H, Wedderburn LR, Nistala K.

Arthritis Rheumatol. 2014 Jul;66(7):1955-60. doi: 10.1002/art.38647.

11.

Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis.

Nistala K, Varsani H, Wittkowski H, Vogl T, Krol P, Shah V, Mamchaoui K, Brogan PA, Roth J, Wedderburn LR.

Arthritis Res Ther. 2013 Sep 23;15(5):R131. doi: 10.1186/ar4311.

12.

Update in juvenile myositis.

Nistala K, Wedderburn LR.

Curr Opin Rheumatol. 2013 Nov;25(6):742-6. doi: 10.1097/01.bor.0000434674.62644.02. Review.

13.

CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines.

Pesenacker AM, Bending D, Ursu S, Wu Q, Nistala K, Wedderburn LR.

Blood. 2013 Apr 4;121(14):2647-58. doi: 10.1182/blood-2012-08-443473. Epub 2013 Jan 25.

14.

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.

Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A, Lovell DJ; PRINTO; PRCSG.

N Engl J Med. 2012 Dec 20;367(25):2396-406. doi: 10.1056/NEJMoa1205099.

15.

Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis.

Omoyinmi E, Hamaoui R, Pesenacker A, Nistala K, Moncrieffe H, Ursu S, Wedderburn LR, Woo P.

Rheumatology (Oxford). 2012 Oct;51(10):1881-6. Epub 2012 Jul 5.

16.

Expression of miRNAs miR-133b and miR-206 in the Il17a/f locus is co-regulated with IL-17 production in αβ and γδ T cells.

Haas JD, Nistala K, Petermann F, Saran N, Chennupati V, Schmitz S, Korn T, Wedderburn LR, Förster R, Krueger A, Prinz I.

PLoS One. 2011;6(5):e20171. doi: 10.1371/journal.pone.0020171. Epub 2011 May 26.

17.

Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection.

Edwards LA, Nistala K, Mills DC, Stephenson HN, Zilbauer M, Wren BW, Dorrell N, Lindley KJ, Wedderburn LR, Bajaj-Elliott M.

PLoS One. 2010 Nov 9;5(11):e15398. doi: 10.1371/journal.pone.0015398.

18.

Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment.

Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, Evans JG, Cimaz R, Bajaj-Elliott M, Wedderburn LR.

Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14751-6. doi: 10.1073/pnas.1003852107. Epub 2010 Aug 2.

19.

High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population.

Moncrieffe H, Nistala K, Kamhieh Y, Evans J, Eddaoudi A, Eaton S, Wedderburn LR.

J Immunol. 2010 Jul 1;185(1):134-43. doi: 10.4049/jimmunol.0803474. Epub 2010 May 24.

20.

Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression.

Hunter PJ, Nistala K, Jina N, Eddaoudi A, Thomson W, Hubank M, Wedderburn LR.

Arthritis Rheum. 2010 Mar;62(3):896-907. doi: 10.1002/art.27284.

Supplemental Content

Loading ...
Support Center